Use

The HIV PhenoSense GT test is designed for patients with viral loads of at least 500 copies/mL. It combines phenotype and genotype testing to assess antiretroviral susceptibility for protease and reverse transcriptase inhibitors. This test is particularly useful for patients with complex drug resistance patterns, as indicated by suboptimal virologic response or viral load rebound, and is preferred to guide treatment in such scenarios.